Rezolute Inc Sustainability Reports
Rezolute, Inc. is a late-stage clinical biopharmaceutical company that develops novel drug therapies for patients with metabolic and orphan diseases. Its lead pipeline programs target congenital hyperinsulinism and diabetic eye diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300T05L48T72P2G08
FIGI: BBG001XWWJC0
2 reports from 2018 to 2024